Akebia Therapeutics, Inc. (AKBA)
1.405
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 15:32
Akebia Therapeutics Market Cap : 376.37M for April 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 4.907B |
| MannKind Corp. | 842.65M |
| Ligand Pharmaceuticals, Inc. | 4.511B |
| Ardelyx, Inc. | 1.462B |
| Rhythm Pharmaceuticals, Inc. | 5.754B |
Market Cap Related Metrics
| PS Ratio | 1.565 |
| Price to Book Value | 11.54 |
| Price to Free Cash Flow | 5.460 |
| Price | 1.405 |
| Earnings Yield | -1.27% |
| Operating PE Ratio | 15.73 |